2'-SEc-butyl-1'-oxo-1',4'-dihydro-2'h-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid

Catalog No. :
ACQIWN149
CAS No. :
1239714-33-0
Molecular Formula :
C18H23NO3
Molecular Weight :
301.39

IUPAC Name:2'-(sec-butyl)-1'-oxo-1',4'-dihydro-2'H-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid

2'-SEc-butyl-1'-oxo-1',4'-dihydro-2'h-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$141.00Login to see priceInquiryInquiry
250mg95%$195.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2'-SEc-butyl-1'-oxo-1',4'-dihydro-2'h-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid
IUPAC Name2'-(sec-butyl)-1'-oxo-1',4'-dihydro-2'H-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid
MDL No.MFCD16630635
Molecular FormulaC18H23NO3
Molecular Weight301.39
SMILESCCC(N1C(C2=CC=CC=C2C(C13CCCC3)C(O)=O)=O)C
InChI KeyKUMXRUUTBNJLKU-UHFFFAOYSA-N
Synonym2-(butan-2-yl)-1-oxo-2,4-dihydro-1H-spiro[cyclopentane-1,3-isoquinoline]-4-carboxylic acid;2-butan-2-yl-1-oxospiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxylic acid;2'-sec-butyl-1'-oxo-1',4'-dihydro-2'H-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxylic acid;MFCD16630635;Spiro[cyclopentane-1,3'(2'H)-isoquinoline]-4'-carboxylic acid, 1',4'-dihydro-2'-(1-methylpropyl)-1'-oxo-
CAS No.1239714-33-0

Synthetic Route by SureRoute

1. ACQIWN149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQIWN149 route product structure diagram
    ACQIWN1491239714-33-0
Inquiry

2. ACQIWN149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQIWN149 route product structure diagram
    ACQIWN1491239714-33-0
Inquiry

Comments (0)